Squarepoint
ANAC

Squarepoint’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

Squarepoint’s Portfolio ANAC Stock Details ANAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-1,900
Closed -$215K – 1722
2015
Q4 		$215K Buy
+1,900
New +$209K 0.02% 966

Other funds holding ANAC

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Squarepoint's ANAC Position: Q1 2016 in Review

Squarepoint sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q1 2016, closing a stake of 1,900 shares — an estimated $215K sold.

Squarepoint first reported a position in ANAC in Q4 2015 and held it in 1 quarter. The position peaked at $215K in Q4 2015. 199 funds tracked by Wall St. Rank hold ANAC as of Q1 2016.

  • Squarepoint reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q1 2016 after selling out during the quarter.
  • Squarepoint sold 1,900 ANACOR PHARMACEUTICALS INC COM shares in Q1 2016, an estimated $215K.
  • Squarepoint first reported a position in ANACOR PHARMACEUTICALS INC COM in Q4 2015 and held it in 1 quarter.
  • Squarepoint's ANACOR PHARMACEUTICALS INC COM position peaked at $215K in Q4 2015.
  • 199 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q1 2016.

Based on Squarepoint's 13F filing for Q1 2016, filed 16 May 2016.